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Objective: Key appetite regulators and their receptors are alady present in the fetal 
hypothalamus, and may respond to hormones such as leptin. Intrauterine food restriction or 
hyperglycemia, can reprogram these circuits, possibly predisposing individuals to adverse 
health outcomes in adulthood. Given the global obesity epidemic, maternal overweight and 
obesity is becoming more prevalent. Previously we observed rapid growth of pups from obese 
dams during the suckling period. However, it is unclear whether this is due to alterations in 
leptin and hypothalamic appetite regulators at birth.   
Design: Female Sprague Dawley rats were fed palatable high-fat-diet or chow for 5 weeks to 
induce obesity before mating. The same diet continued during gestation. At day 1 after birth, 
plasma and hypothalamus were collected from male and female pups.  
Measurements: Body weight and organ mass were recorded. Leptin and insulin levels were 
measured in the plasma by radioimmunoassay. Hypothalamic mRNA expression of 
neuropeptide Y, pro-opiomelanocortin, leptin receptor and its downstream signal STAT3 
were measured using real-time PCR. 
Results: Body and organ weights of pups from obese dams were similar to those from lean 
dams, across both genders. However, plasma leptin levels were significantly lower in 
offspring from obese dams (male: 0.53 ± 0.13 vs. 1.05 ± 0.21 ng/ml; female: 0.33 ± 0.09 vs. 
2.12 ± 0.57 ng/ml, respectively; both P < 0.05). Hypothalamic mRNA expression of 
neuropeptide Y, pro-opiomelanocortin, leptin receptor and STAT3 were also significantly 
lower in pups from obese dams.  
Conclusion: Long-term maternal obesity, together with lower leptin levels in pups from 
obese dams may contribute to the lower expression of key appetite regulators on day 1 of life, 
suggesting altered intrauterine neuron development in response to intrauterine overnutrition, 
which may contribute to eating disorders later in life. 
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The central neural network regulating appetite is present before birth in rodents and higher-
order mammals. In the rat, the differentiation of the neuronal systems responsible for appetite 
and energy expenditure begins during the last week of gestation, with development continuing 
until weaning (1). The development and maturation of these pathways depend on the “leptin 
surge”, which appears between postnatal days 6 to 14, characterized by a sudden increase in 5 
circulating leptin levels (2).  
 
Leptin, also termed the ob protein, is produced predominantly by adipocytes, and early onset 
obesity is seen in the absence of either leptin protein or its receptor (3). The key signaling 
form, the long form of the leptin receptor (Ob-Rb), is found in hypothalamic areas involved in 10 
appetite and metabolic regulation (4). The intracellular domain of Ob-Rb binds to signal 
transducer and activator of transcription (STAT)3, to induce expression of a signaling 
inhibitor, suppressor of cytokine signaling (SOCS)3 (4). In adult rodents, leptin decreases 
fasting-induced hyperphagia, and reduces normal daily food intake, body weight and fat 
accumulation (4), by suppressing the hypothalamic orexigenic peptides, neuropeptide Y (NPY) 15 
and agouti-related protein (AgRP), and stimulating the anorexigenic peptides, pro-
opiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (5).  
 
However, in the pre-weaning rodent, leptin plays a different role to that in the adult animal, 
which appears to be independent of its role in energy homeostasis (2, 6). Exogenous leptin 20 
does not reduce body weight, milk intake, or metabolic rate during the first two postnatal 
weeks (7), rather it can actually promote voluntary eating and hyperphagia during this period 
(8). This is of importance, as neonatal rodents need to maximize food intake and also maintain 
a high thermoregulatory metabolic rate to favour survival. The differentiation of the neuronal 
systems that regulate appetite and energy expenditure is not complete until weaning (1).  25 
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Increased circulating leptin during the “leptin surge” supports the development and 
maturation of the central neurons involved in appetite and energy metabolism regulation (2). 
Leptin deficiency in ob/ob mice results in a lower hypothalamic neuron density and 
innervation, which is thought to contribute to the obese phenotype (6, 9). The high postnatal 
“leptin surge” due to restricted intrauterine nutrition has been shown to be linked to an 5 
increased expression of hypothalamic NPY peptide, which may be responsible for increased 
weight gain and adiposity when animals are fed a high-fat diet (HFD) after weaning (10). 
 
The intrauterine environment exerts an important role in fetal development and determination 
of risk of obesity and metabolic disorders such as glucose intolerance and hypertension in 10 
later life (11). Intrauterine undernutrition related catch up growth and increased risk of obesity 
has been thoroughly studied to date. However, given th  global obesity epidemic, there is a 
need to understand the impact of maternal overnutrition on the fetal hypothalamic circuitry 
involved in energy homeostasis. There are increasing numbers of women entering pregnancy 
are overweight or obese (12). Intrauterine overnutrition due to maternal obesity has been 15 
linked childhood obesity. Few laboratories have studied the neuroendocine impact of maternal 
obesity due to long-term high-fat diet (HFD) feeding on offspring (13, 14).  
 
Previously, we observed that offspring from obese dams were born with similar body weights 
as those from lean dams, whereas their weight gain accelerated soon after birth, becoming 20 
significantly heavier than those from lean dams after postnatal day 10 (13). However, little is 
known regarding how intrauterine overnutrition due to maternal HFD feeding reprograms 
metabolism, especially hypothalamic appetite regulators in the pups, to promote growth 
shortly after birth. Thus we hypothesized that at dy 1 of life, pups born from obese dams 
would have increased plasma leptin and expression of hypothalamic NPY, but reduced POMC 25 
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mRNA expression, promoting increased milk intake, leading to rapid growth immediately 
after birth.  
 
Materials and Methods 
Maternal obesity 5 
Virgin outbred female Sprague Dawley rats (8 weeks, Animal Resources Centre, Perth, 
Australia), were housed at 20 ± 2°C, and maintained on a 12:12 h light/dark cycle (lights on at 
06:00h). Rats were assigned to two groups of similar average body weight. The control group 
was exposed to standard laboratory chow (Gordon’s Specialty Stockfeeds, NSW, Australia) 
providing 11 kJ/g (14% energy as fat), while the second group was presented with a palatable 10 
cafeteria HFD providing 15.33 kJ/g (34% energy as fat). Briefly, the HFD consisted of high-
fat modified chow (standard chow, milk powder, sweeten d condensed milk and saturated 
animal fat) and highly palatable cafeteria style food such as cakes and biscuits (4-5 different 
food types per day) of known caloric content. Fresh food was provided daily. Female rats 
were exposed to either chow or HFD for 5 weeks before mating with male rats (aged 9 weeks) 15 
obtained from the same source. The current study was approved by the Animal Ethics 
Committee of the University of New South Wales. 
 
2. Sample collection  
On day 1 after birth, pups of both genders were separated from their mothers and killed 20 
immediately by decapitation. Trunk blood was collected and blood glucose was measured 
(Accu-Chek® glucose meter; Roche Diagnostics, USA). Separated plasma was stored at -20°C 
for hormone measurements. The whole hypothalamus was dissected and snap frozen in liquid 
nitrogen, and stored at -80°C for determination of mRNA expression of genes of interest. 




3. Plasma leptin and insulin measurements 
Plasma leptin and insulin concentrations were measur d using commercially available 
radioimmunoassay kits (Linco, Missouri, USA), according to the manufacturers’ instructions. 
The detection limits for leptin and insulin were 0.125 and 0.05ng/ml respectively.  5 
 
4. Quantitative real-time PCR 
Total RNA was isolated from individual hypothalamus of males and females using TriZol 
reagent (Invitrogen Australia Pty Limited, Australia) according to the manufacturer’s 
instructions. The purified total RNA was used as a template to generate first-strand cDNA 10 
synthesis using M-MLV Reverse Transcriptase, RNase H Minus, Point Mutant Kit (Promega, 
USA). Applied Biosystem probe/primers (Foster City, CA, USA) that were pre-optimized and 
validated were used for quantitative real-time PCR (Eppendorf Realplex 2, Germany). The 
sequence of probes provided by the manufactor is listed in Table 1. The target gene probes 
were labeled with FAM and 18s rRNA was labeled with VIC. Thus gene expression was 15 
quantified in a single multiplexing reaction, where our gene of interest was standardized to 
housekeeping gene (18s rRNA). An individual sample from the control group was then 
arbitrarily assigned as a calibrator against which all other samples are expressed as fold 
difference. 
 20 
5. Statistical methods 
Results are expressed as mean ± SEM. Data were analysed by Shafario Wilks test for 
normality (Graphpad Prism 5). Ifdata were normally distributed, they were analyzed by 
Student’s unpaired t test. If they were not, they were log transformed to normal distribution 





Before the dietary intervention began, body weights between the groups of females were 
similar (chow-fed 183.0 ± 3.8 g vs. HFD-fed 183.9 ± 4.3 g). Before mating, HFD-fed female 
rats were 29% heavier than the chow-fed rats (295.2 ± 11.1 g vs. 229.5 ± 7.54 g, respectively; 5 
P < 0.05). At sacrifice, body weight of obese dams wa  30% greater than that of lean dams 
(P< 0.05, Table 2). Although the increase in liver w ight was not significant, heart weight was 
significantly increased by 14% in HFD-fed dams compared with chow-fed dams. BAT, 
retroperitoneal, mesentery and uterine fat masses were about 3 times greater in the HFD-fed 
dams (Table 2). Blood glucose and plasma insulin concentrations also appeared higher in the 10 
obese dams; however, this did not reach statistical significance. Plasma triglycerides and 
leptin levels were significantly increased by 3 and 1.7 times respectively in the obese rats (P< 
0.05, Table 2). The average litter size for chow-fed mothers was 9.9 and 10.0 for HFD-fed 
dams.  
 15 
At day 1, the male pups from lean dams were 11% heavier than the female pups (Tables 3, 4). 
There were no significant differences in body weight or organ weights in response to maternal 
HFD feeding across both genders (Tables 3, 4). In pups from lean dams, insulin and leptin 
concentration of females was higher than males. In both genders, blood glucose and plasma 
insulin of pups from obese dams were slightly higher than those from lean dams without 20 
reaching statistical significance. Interestingly, plasma leptin levels were significantly lower in 
pups from obese dams versus lean dams in both genders, and this was more marked in 
females (P < 0.05, maternal diet effect in both genders, Tables 3, 4). Across both dietary 
groups, plasma leptin was also positively correlated with day 1 body weight in both genders 




The Ct value of the housekeeping gene 18s was not changed by maternal overnutrition across 
genders (male pup: lean dam 16.13 ± 0.15 vs. obese dam 16.29 ± 0.40; female pup: lean dam 
15.88 ± 0.28 vs. obese dam 15.67 ± 0.18, n = 5-6). Both male and female pups responded to 
maternal overnutrition in a similar fashion, and changes in hypothalamic mRNA expression 5 
were also similar across genders. In male pups, mRNA expression of hypothalamic NPY, 
POMC, melanocortin 4 receptor (MC4R), leptin receptor (Ob-Rb), STAT3, SOCS3, and the 
fuel sensor, mammalian target of rapamycin (mTOR), were significantly lower in the pups 
from obese dams compared to those from lean dams (P < 0.05, Figs 1, 2); whereas AgRP 
mRNA expression was at a similar level between the two groups (Fig 1B). In female pups, 10 
mRNA expression of NPY, MC4R, and Ob-Rb were signifcantly reduced in pups from obese 
dams (P < 0.05, Fig 3A, 3E, 4A). There was some reduction in AgRP, POMC, and SOCS3 
expression; however these did not reach statistical s gnificance (Fig 3B, 3D, 4C). mTOR and 
STAT3 mRNA expression was not altered by maternal obesity in female pups. 
 15 
Discussion 
Here we describe, for the first time, significantly reduced plasma leptin levels, as well as 
downregulation of its receptor and downstream signal STAT3, in postnatal day 1 offspring 
from obese dams. Contrary to our hypothesis, reduced expression of the key hypothalamic 
appetite regulating peptides, NPY and POMC was observed in offspring from obese dams. 20 
These data demonstrate a major impact of maternal overnutrition on neuroendocrine appetite 
regulation in newborn offspring. 
 
Leptin is produced in multiple sites apart from white adipose tissue, including the stomach, 
placenta, and certain fetal organs such as the heart, bone and cartilage (15-20). Breast milk 25 
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can also provide the newborn with an important source of leptin (21, 22). However, in this 
study, 1-day old pups were only fed for 24 hours. Thus leptin from milk is unlikely to 
markedly affect their circulating leptin levels at this time point. It is well accepted that in 
humans gestational diabetes causes high leptin levels in offspring, while the opposite is 
observed in small for gestational age babies (23, 24). This may be due to the difference in 5 
adiposity, because in the human embryo, leptin is mainly sourced from developing fat cells 
(25). However, adipose tissue was hardly detectable in newborn pups from either obese or 
lean dams in our study. The placenta can produce leptin, with a small amount (1.6%) released 
into the fetal circulation (25, 26). It has been documented that maternal circulating leptin 
crosses the blood-placental barrier into the fetal circulation and plays an important role in 10 
fetal development (27). While elucidating the mechanism underlying the reduced circulating 
leptin in offspring of obese dams requires further work, it is likely that a high level of 
maternal leptin reduced its production from fetal organs, leading to lower plasma leptin 
shortly after birth. Another explanation is that hig  maternal circulating triglyceride levels 
may reduce leptin transport at the blood-placenta barrier to cause fetal deficiency, since 15 
triglycerides decrease leptin transport at the blood-brain barrier (28). Further studies are 
needed to confirm this. The low leptin at postnatal day 1 seems at odds with the similar body 
weight and organ mass between pups from obese and le  dams since leptin is important for 
fetal growth (25). Pups from obese dams would receiv  higher levels of nutrients, such as 
triglycerides, from the maternal circulation to support their growth. Interestingly, unchanged 20 
or lower birth weight has been observed in offspring from obese mothers in genetically obese-
prone and palatable cafeteria HFD induced obese rats (29-31), which may be due to the 




Newborn humans with either high or low leptin levels at birth have a higher risk of 
developing obesity and type 2 diabetes compared with those who have normal leptin levels 
(23, 32). We did find that pups from obese dams had greater weight gain during the suckling 
period and lay down fat tissue at a faster rate than ose from lean dams after birth, resulting 
in 10 times greater retroperitoneal fat mass at day 7 fter birth. At this time, plasma leptin 5 
levels were increased compared pups from lean dams (unpublished data), which may be due 
to the richer maternal milk or increased fat mass (30). The increase in both adiposity and 
circulating leptin levels in offspring from obese dams persisted until postnatal day 20 (13).  
 
Newborn leptin levels are suggested to be correlated with levels of insulin and insulin-like 10 
growth factor-1 (33). In the current study, insulin levels were higher in the female pups than 
male pups, as recorded previously in the literature (34). However it was not significantly 
changed by maternal obesity. It has been suggested that leptin signaling pathways in the 
neonatal hypothalamus do not develop until after the 6th postnatal day (7, 35), and the 
expression of Ob-Rb does not affect leptin penetrating the blood brain barrier (36); whereas a 15 
population of arcuate Ob-Rb expressing neurons can be directly accessed by circulating leptin 
(37). Downregulated STAT3 mRNA expression in male pups at day 1 may lead to a lower 
responsiveness to leptin in the offspring of obese dams even if they obtain leptin from 
maternal milk or adipocytes and other organs later on. On the other hand, the reduction in 
SOCS3 expression observed may compensate for the reduced Ob-Rb and STAT3. It is 20 
interesting to see the gender difference on hypothalamic STAT3 expression, which was not 
reduced in the female pups as in the males. Cross talk between leptin and insulin pathways 
has been well documented, as insulin can increase the phosphorylation of STAT3 either 
directly or via leptin (38, 39). Plasma insulin was increased by 61% in female offspring from 
obese dams compared with those from lean dams. Although this did not reach statistical 25 
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significance, the increased insulin level may contribu e to the hypothalamic STAT3 mRNA 
expression in female pups from obese dams.  
 
Although birth weight and organ masses were not affected by maternal obesity, our data 
suggest that the low circulating leptin in pups from bese dams regulates the production of 5 
hypothalamic neurotransmitters involved in energy homeostasis. Unlike adult animals where 
low plasma leptin is associated with increased NPY, in newborn rats, leptin may stimulate the 
production of hypothalamic neuropeptides or neurite growth. Key hypothalamic 
neurotransmitters were significantly altered at birh by intrauterine overnutrition. In pups from 
obese dams, production of hypothalamic appetite regulatory peptides (NPY, POMC), the fuel 10 
sensor (mTOR), and MC4R were reduced, together with lower expression of leptin receptors 
and its downstream signaling system. It is interesting to observe no alteration in AgRP mRNA 
expression between groups. Brain AgRP mRNA expression appeared at gestation day 14 in 
rats, however the level was dramatically decreased to undetectable level at gestation day 18 
(40). Thus, it is possible that in newborns, AgRP reappears and thus was less affected by the 15 
degree of maternal nutrition. The relative importance of NPY and AgRP in voluntary suckling 
needs further investigation. In adult animals, hypothalamic NPY and POMC are 
downregulated in the face of HFD feeding, whereas MC4R mRNA expression is upregulated 
(41-43). In the current study, mRNA expression of MC4R was reduced by maternal obesity. 
MC4R is critical for normal control of food intake (44), as MC4R-selective agonists cause 20 
dose dependent hypophagia and weight loss, whereas MC4R-selective antagonists or MC4-R 
knockout cause markedly increased food intake obesity (45, 46).  Thus the reduction in 
MC4R mRNA and unchanged AgRP expression, alongside reduced POMC mRNA, in 
offspring of obese dams may promote hyperphagia. mTOR is a newly identified hypothalamic 
sensor of fuels such as amino acids and glucose, whose activation leads to reduced food 25 
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intake and body weight gain; inhibition of mTOR can also diminish the effects of leptin (47). 
Reduced hypothalamic mTOR mRNA expression in male newborns from obese dams may 
affect nutrient sensing and thus increase milk intake s we observed in postnatal day 10 pups 
(Chen and Morris, unpublished data). However, here mTOR was differently programmed in 
the female pups. We suggest that it could be consistent with unchanged STAT3, since leptin 5 
can directly activate mTOR (47).    
 
After birth, maternal milk will start to supply leptin to the pup, and with the differentiation of 
adipocytes, endogenous production of leptin will also catch up in pups from obese dams. 
Whether this will over compensate and cause a higher “leptin surge” leading to faster growth 10 
during the suckling period is under further investiga on. Another important question is 
whether these hypothalamic adaptations to maternal obesity are long-lasting. However, our 
results demonstrate that marked changes in key hypot alamic appetite regulators at postnatal 
day 1 are induced by maternal obesity, which may promote overeating in offspring. Low 
neonatal plasma leptin in leptin deficient ob/ob mice and following intrauterine nutrition 15 
restriction in rats resulted in disturbed neural development during suckling period and obesity 
at adulthood (48, 49), while leptin injection during the early postnatal period ameliorated the 
obese phenotype (48, 50), suggesting early postnatal leptin supplementation may reverse the 




Funding: This work was supported by project grant funding from the National Health and 




1. Grove KL, Grayson BE, Glavas MM, Xiao XQ, Smith MS. Development of metabolic 
systems. Physiol Behav 2005; 86: 646-660. 
2. Ahima RS, Prabakaran D, Flier JS. Postnatal leptin surge and regulation of circadian 
rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine 
function. J Clin Invest 1998; 101: 1020-1027. 
3. Wynne K, Stanley S, McGowan B, Bloom S. Appetite control. J Endocrinol 2005; 
184: 291-318. 
4. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. 
Nature 1998; 395: 763-770. 
5. Schwartz MW, Woods SC, Porte DJ, Seeley RJ, Baskin DG. Central nervous system 
control of food intake. Nature 2000; 404: 661-671. 
6. Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, et al. Rapid rewiring 
of arcuate nucleus feeding circuits by leptin. Science 2004; 304: 110-115. 
7. Mistry AM, Swick A, Romsos DR. Leptin alters metabolic rates before acquisition of 
its anorectic effect in developing neonatal mice. Am J Physiol Regul Integr Comp 
Physiol 1999; 277: R742-747. 
8. Roberts TJ, Nijland MJ, Caston-Balderrama A, Ross MG. Central leptin stimulates 
ingestive behavior and urine flow in the near term ovine fetus. Horm Metab Res 2001; 
33: 144-150. 
9. Bouret SG, Simerly RB. Developmental programming of hypothalamic feeding 
circuits. Clin Genet 2006; 70: 295-301. 
10. Yura S, Itoh H, Sagawa N, Yamamoto H, Masuzaki H, Nakao K, et al. Role of 
premature leptin surge in obesity resulting from intrauterine undernutrition. Cell 
Metab 2005; 1: 371-378. 
15 
 
11. Iliadou A, Cnattingius S, Lichtenstein P. Low birthweight and Type 2 diabetes: A 
study on 11 162 Swedish twins. Int J Epidemiol 2004; 33: 948-953. 
12. Yeh J, Shelton JA. Increasing prepregnancy body mass index: analysis of trends and 
contributing variables. Am J Obest Gynecol 2005; 193: 1994-1998. 
13. Chen H, Simar D, Lambert K, Mercier J, Morris MJ. Intrauterine and postnatal 
overnutrition differentially impact appetite regulators and fuel metabolism. 
Endocrinology 2008: 10.1210/en.2008-0582. 
14. Samuelsson A-M, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen 
EHJM, et al. Diet-induced obesity in female mice leads to offspring hyperphagia, 
adiposity, hypertension, and insulin resistance. A novel murine model of 
developmental programming. Hypertension 2007; 51: 383-392. 
15. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional 
cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-
432. 
16. Bi S, Gavrilova O, Gong DW, Mason MM, Reitman M. Identification of a placental 
enhancer for the human leptin gene. J Biol Chem 1997; 272: 30583-30588. 
17. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, et al. 
Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in 
humans. Nat Med 1997; 3: 1029-1033. 
18. Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, et al. 
The stomach is a source of leptin. Nature 1998; 394: 790-793. 
19. Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, Mercer JG. Leptin and 
leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc 
Natl Acad Sci USA 1997; 94: 11073-11078. 
16 
 
20. Wilkinson M, Brown R, Imran SA, Ur E. Adipokine gene expression in brain and 
pituitary gland. Neuroendocrinology 2007; 86: 191-209. 
21. Stocker CJ, Wargent E, O'Dowd J, Cornick C, Speakman JR, Arch JRS, et al. 
Prevention of diet-induced obesity and impaired glucose tolerance in rats following 
administration of leptin to their mothers. Am J Physiol Regul Integr Comp Physiol 
2007; 292: R1810-1818. 
22. Miralles O, Sanchez J, Palou A, Pico C. A physiological role of breast milk leptin in 
body weight control in developing infants. Obesity 2006; 14: 1371-1377. 
23. Persson B, Westgren M, Celsi G, Nord E, Ortqvis E. Leptin concentrations in cord 
blood in normal newborn infants and offspring of diabetic mothers. Horm Metab Res 
1999; 31: 467-471. 
24. Gross GA, Solenberger T, Philpott T, Holcomb WL, Landt M. Plasma leptin 
concentrations in newborns of diabetic and nondiabet c mothers. Am J Perinatol 1998; 
15: 243-247. 
25. Bajoria R, Sooranna SR, Ward BS, Chatterjee R. Prospective function of placental 
leptin at maternal-fetal interface. Placenta 2002; 23: 103-115. 
26. Desoye G, Hauguel-de Mouzon S. The human placent  in gestational diabetes mellitus. 
The insulin and cytokine network. Diabetes Care 2007; 30 Suppl 2: S120-126. 
27. Smith JT, Waddell BJ. Leptin distribution and metabolism in the pregnant rat: 
transplacental leptin passage increases in late gesation but is reduced by excess 
glucocorticoids. Endocrinology 2003; 144: 3024-3030. 
28. Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, et al. 




29. Bayol SA, Farrington SJ, Stickland NC. A maternal 'junk food' diet in pregnancy and 
lactation promotes an exacerbated taste for 'junk food' and a greater propensity for 
obesity in rat offspring. Br J Nutr 2007; 98: 843-851. 
30. Gorski JN, Dunn-Meynell AA, Hartman TG, Levin BE. Postnatal environment 
overrides genetic and prenatal factors influencing offspring obesity and insulin 
resistance. Am J Physiol Regul Integr Comp Physiol 2006; 291: R768-778. 
31. Caluwaerts S, Lambin S, van Bree R, Peeters H, Vergote I, Verhaeghe J. Diet-induced 
obesity in gravid rats engenders early hyperadiposity in the offspring. Metabolism 
2007; 56: 1431-1438. 
32. Ben X, Qin Y, Wu S, Zhang W, Cai W. Placental leptin correlates with intrauterine 
fetal growth and development. Chin Med J 2001; 114: 636-639. 
33. Christou H, Serdy S, Mantzoros CS. Leptin in relation to growth and developmental 
processes in the fetus. Semin Reprod Med 2002; 20: 123-130. 
34. Wilkin TJ, Murphy MJ. The gender insulin hypothesis: why girls are born lighter than 
boys, and the implications for insulin resistance. Int J Obes 2006; 30: 1056-1061. 
35. Bouret SG, Draper SJ, Simerly RB. Formation of pr jection pathways from the 
arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural 
control of feeding behavior in mice. J Neurosci 2004; 24: 2797-2805. 
36. Pan W, Hsuchou H, Tu H, Kastin AJ. Developmental ch nges of leptin receptors in 
cerebral microvessels: unexpected relation to leptin transport. Endocrinology 2008; 
149: 877-885. 
37. Faouzi M, Leshan R, Bjornholm M, Hennessey T, Jones J, Munzberg H. Differential 
accessibility of circulating leptin to individual hypothalamic sites. Endocrinology 
2007; 148: 5414-5423. 
18 
 
38. Benomar Y, Roy AF, Aubourg A, Djiane J, Taouis M. Cross down-regulation of leptin 
and insulin receptor expression and signalling in a human neuronal cell line. Biochem 
J 2005; 388: 929-939. 
39. Carvalheira JB, Siloto RM, Ignacchitti I, Brenelli SL, Carvalho CR, Leite A, et al. 
Insulin modulates leptin-induced STAT3 activation in rat hypothalamus. FEBS Lett 
2001; 500: 119-124. 
40. Beloosesky R, Gayle DA, Amidi F, Ahanya SN, Desai M, Ross MG. Ontogenic 
expression of putative feeding peptides in the rat fet l brain and placenta. Nutr 
Neurosci 2006; 9: 33-40. 
41. Hansen MJ, Jovanovska V, Morris MJ. Adaptive responses in hypothalamic 
neuropeptide Y in the face of prolonged high-fat feeding in the rat. J Neurochem 2004; 
88: 909-916. 
42. Morris MJ, Chen H, Watts R, Shulkes A, Cameron-Smith D. Brain neuropeptide Y 
and CCK and peripheral adipokine receptors: temporal response in obesity induced by 
palatable diet. Int J Obes 2008; 32: 249-258. 
43. Huang XF, Han M, South T, Storlien L. Altered lvels of POMC, AgRP and MC4-R 
mRNA expression in the hypothalamus and other parts of the limbic system of mice 
prone or resistant to chronic high-energy diet-induced obesity. Brain Res 2003; 992: 
9-19. 
44. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, et al. Divergence 
of melanocortin pathways in the control of food intake and energy expenditure. 
Comment in: Cell 2004 Oct 29;119(3):313-4 2005; 123: 493-505. 
45. Benoit SC, Schwartz MW, Lachey JL, Hagan MM, Rushing PA, Blake KA, et al. A 
novel selective melanocortin-4 receptor agonist reduc s food intake in rats and mice 
without producing aversive consequences. J Neurosci 2000; 20: 3442-3448. 
19 
 
46. Hansen MJ, Schioth HB, Morris MJ. Feeding respon es to a melanocortin agonist and 
antagonist in obesity induced by a palatable high-fat diet. Brain Res 2005; 1039: 137-
145. 
47. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, et al. Hypothalamic 
mTOR signaling regulates food intake. Science 2006; 312: 927-930. 
48. Bouret SG, Draper SJ, Simerly RB. Trophic action of leptin on hypothalamic neurons 
that regulate feeding. Science 2004; 304: 108-110. 
49. Delahaye F, Breton C, Risold PY, Enache M, Dutriez-Casteloot I, Laborie C, et al. 
Maternal perinatal undernutrition drastically reduces postnatal leptin surge and affects 
the development of arcuate nucleus proopiomelanocortin neurons in neonatal male rat 
pups. Endocrinology 2008; 149: 470-475. 
50. Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, et al. 







Table 1: TaqMan probe sequence (Applied Biosystem, Foster City, USA) used for real time-PCR. 
Gene NCBI gene references FAM-labeled Probes (5’→ 3 ) Applied Biosystem Assay 
Ob-Rb NM_012596.1 TTAATTTCCAAAAGCCTGAAACATT Rn01433205_m1 
mTOR XM_213539.4 AACCTGATCGCCTGTGGCTCCATGA Rn01464435_g1 
MC4R NM_013099.2 AGCAGAAGCCTGATTCCACTGTTTA Rn01491866_s1 
NPY NM_012614.1 GCCCGCCCGCCATGATGCTAGGTAA Rn0056168_m1 
POMC NM_139326.2 AAGCAACCTGCTGGCTTGCATCCGG Rn00595020_m1 
SOCS3 NM_053565.1 ACCCCCGGAGCACGCAGCCAGTGCC Rn00585674_s1 




Table 2 Parameters of breeders at kill 
 Chow-fed dam HFD-fed dam 
  (n = 10) (n = 9) 
BW (g) 353.9 ± 10.7 462.4 ± 32.3 * 
Liver (g) 12.17 ± 0.44 13.09 ± 0.95 
Heart (g) 0.97 ± 0.03 1.11 ± 0.04 * 
BAT (g) 0.25 ± 0.05  0.75 ± 0.15 * 
Retroperitoneal fat (g) 3.95 ± 1.07 13.39 ± 1.43 * 
Mesenteric fat (g) 5.79 ± 1.10 16.58 ± 3.97 * 
Uterine fat (g) 7.69 ± 1.40 19.88 ± 2.12 * 
Blood glucose (mM) 10.68 ± 0.82 12.35 ± 1.21 
Plasma triglycerides (mM) 0.39 ± 0.12 1.71 ± 0.48 * 
Plasma insulin (ng/ml)  0.15 ± 0.06 0.37 ± 0.11 
Plasma leptin (ng/ml)  8.22 ± 1.55 16.25 ± 1.41 * 
Results are expressed as mean ± S.E.M. Data were analysed by unpaired student’s -test.  




Table 3 Parameters of 1-day-old male pups 
 Chow-fed dam HFD-fed dam 
  (n = 7) (n = 9) 
BW (g) 6.68 ± 0.57 6.65 ± 0.42 
Liver (mg)  286.89 ± 22.68 271.69 ± 16.36 
Liver (%BW) 4.57 ± 0.33 4.11 ± 0.14 
Heart (mg) 39.64 ± 3.07 43.04 ± 2.77 
Heart (%BW) 0.63 ± 0.04  0.65 ± 0.02 
Stomach (mg) 314.81 ± 65.85 357.96 ± 53.17 
Stomach (%BW) 4.79 ± 0.70 5.15 ± 0.58 
Blood glucose 4.47 ± 0.49 4.77 ± 0.36 
Plasma insulin (ng/ml)  0.18 ± 0.04 0.21 ± 0.05 
Plasma leptin (ng/ml)  1.05 ± 0.21 0.53 ± 0.13*  
Results are expressed as mean ± S.E.M. Data were analysed by unpaired student’s -test. 




Table 4 Parameters of 1-day-old female pups 
 Chow-fed dam HFD-fed dam 
  (n = 9) (n = 7) 
BW (g) 5.99 ± 0.17 5.94 ± 0.36 
Liver (mg)  259.51 ± 10.59 250.15 ± 20.01 
Liver (%BW) 4.36 ± 0.21 4.21 ± 0.23 
Heart (mg) 37.86 ± 2.25 37.33 ± 3.57 
Heart (%BW) 0.63 ± 0.02  0.63 ± 0.03 
Stomach (mg) 248.90 ± 31.86 248.15 ± 51.98 
Stomach (%BW) 4.12 ± 0.50 4.02 ± 0.61 
Blood glucose 4.49 ± 0.41 4.93 ± 0.46 
Plasma insulin (ng/ml) 0.36 ± 0.08 0.58 ± 0.17 
Plasma leptin (ng/ml)  2.12 ± 0.57 0.33 ± 0.09* 
Results are expressed as mean ± S.E.M. Data were analysed by unpaired student’s -test. 




Fig1: Hypothalamic NPY (A), AgRP (B), mTOR (C), POMC (D) and MC4R (E) mRNA 
expression in male pups of chow (open bars n = 6) and HFD-fed (closed bars n = 5) dams. 
Results are expressed as mean ± S.E.M. Data were analysed by unpaired student’s -test.  
* P < 0.05 significantly different from pups of chow-fed dams.  
 
Fig 2: Hypothalamic Ob-Rb (A), STAT3 (B) and SOCS3 (C) mRNA expression in male pups 
of chow (open bars n = 6) and HFD-fed (closed bars n = 5) dams. Results are expressed as 
mean ± S.E.M. Data were analysed by unpaired studen’s t-test.  
* P < 0.05 significantly different from pups of chow-fed dams.  
 
Fig3: Hypothalamic NPY (A), AgRP (B), mTOR (C), POMC (D) and MC4R (E) expression 
in female pups of chow (open bars n = 6) and HFD-fed (closed bars n = 6) dams. Results are 
expressed as mean ± S.E.M. Data were analysed by unpaired student’s t-test.  
* P < 0.05 significantly different from pups of chow-fed dams. 
 
Fig 4: Hypothalamic Ob-Rb (A), STAT3 (B) and SOCS3 (C) mRNA expression in female 
pups of chow (open bars n = 6) and HFD-fed (closed bars n = 6) dams. Results are expressed 
as mean ± S.E.M. Data were analysed by unpaired studen ’s t-test.  
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